tirzepatide and parkinson's disease GLP-1 does not slow progression in phase 3 study Parkinson Disease Drugs - Neurology

It says every increase should occur under qualified provider supervision with that assessment recorded, so there is a record of how the previous step was handled

The commercial success of prescription weight loss medications is hard to ignore

If someone shares a dosing chart online without specifying concentration, there is a reasonable chance they are talking about 5mg/mL

Disclosure: I am an independent LifeWave Brand Partner

Drink enough fluids and include whole foods to support your metabolism

320 These observations were confirmed in ob/ob mice and high-fat-fed mice when they were treated with a GIPR antagonist, and also in mice lacking GIP-secreting K cells, confirming the important role of GIP in fat accumulation